AGL 2043

SKU: orb1701242

Description

AGL 2043 is a reversible and ATP-competitive small molecule inhibitor targeting type III receptor tyrosine kinases. It is utilized in biochemical and cellular assays to investigate kinase signaling pathways in oncology and cardiovascular research, as evidenced by its application in published in vitro studies.

Research Area

Cancer Biology, Cardiovascular Research, Signal Transduction

Key Properties

• CAS Number: 226717-28-8
• MW: 280.35
• Formula: C₁₅H₁₂N₄S
• SMILES: CN1C=2C(=CC=3C(C2)=NC=C(N3)C4=CC=CS4)N=C1C
• Target: PDGFR,Others,FLT

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

9817165